Researcher
Philippe Nafteux
- Disciplines:Respiratory medicine
Affiliations
- Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE) (Division)
Member
From1 Jan 2020 → Today - Thoracic Surgery (Division)
Member
From25 Feb 2008 → 31 Dec 2019
Projects
1 - 10 of 12
- Neoadjuvant therapy in the treatment of esophageal adenocarcinoma: one size doesn’t fit allFrom14 Nov 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Multicenter validation trial of [18F]AlF-FAPI-74 for PET imaging of cancer-associated fibroblasts through fibroblast activation protein inhibitors (FAPI) in digestive tumorsFrom1 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Prevention of infectious complications after esophageal resectionFrom20 Sep 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Breath Analysis In Esophageal Cancer: The evolution towards minimally invasive patient-tailored diagnosticsFrom25 Jan 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Personalized multimodal treatment for resectable esophageal cancer by detecting minimal residual disease (MRD) using circulating tumor DNA (ctDNA):From11 Jan 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Implementation, optimisation and evaluation of proton therapy in esophageal cancerFrom1 Oct 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- EFFECTS trial: assessing the influence of timing of Enteral Feeding support in Esophageal Cancer patients on muscle functTION and SurvivalFrom1 Oct 2018 → 30 Sep 2022Funding: FWO Applied Biomedical Research (TBM)
- " Is lymph node response an important prognosticator in esophageal adenocarcinoma patients after neoadjuvant chemoradiation followed by surgery? "From31 May 2018 → 30 Dec 2019Funding: Own budget, for example: patrimony, inscription fees, gifts
- Exploring strategies to reduce toxicity in the multimodal treatment of esophageal cancerFrom1 Jun 2017 → 31 May 2021Funding: Nonprofit institution or equivalents
- Detection of circulating tumor cells in potentially resectable adenocarcinoma of the distal esophagus and the gastro-esophageal junction does not increase in portal venous blood samples compared to peripheral venous blood samples.From1 Jan 2017 → 31 Dec 2019Funding: Own budget, for example: patrimony, inscription fees, gifts
Publications
1 - 10 of 204
- Diagnosis and Management of Esophageal Fistulas After Lung Transplantation: A Case Series.(2024)
Authors: Stijn Vanstraelen, Robin Vos, Jan Van Slambrouck, Paul De Leyn, Hans Van Veer, Lieven Depypere, Raf Bisschops, Ingrid Demedts, Michael Casaer, Yves Debaveye, et al.
Pages: e1593 - Outcomes after Surgical Treatment of Oesophagogastric Cancer with Synchronous Liver Metastases: A Multicentre Retrospective Cohort Study(2024)
Authors: Johnny Moons, Philippe Nafteux
- Proton versus photon therapy for esophageal cancer - A trimodality strategy (PROTECT) NCT050555648: A multicenter international randomized phase III study of neoadjuvant proton versus photon chemoradiotherapy in locally advanced esophageal cancer(2024)
Authors: Pieter Populaire, Philippe Nafteux, Gilles Defraene, Karin Haustermans
- ASO Visual Abstract: Major Intraoperative Complications During Minimally Invasive Esophagectomy(2023)
Authors: Johnny Moons, Philippe Nafteux
- Major Intraoperative Complications During Minimally Invasive Esophagectomy.(2023)
Authors: Johnny Moons, Philippe Nafteux
Pages: 8244 - 8250 - The Belsey Mark IV procedure in the era of minimally invasive antireflux surgery(2023)
Authors: Lieven Depypere, Hans Van Veer, Johnny Moons, Philippe Nafteux
- Clinical implications of dose to functional lung volumes in the trimodality treatment of esophageal cancer(2023)
Authors: Pieter Populaire, Gilles Defraene, Philippe Nafteux, Lieven Depypere, Johnny Moons, Karin Haustermans
Pages: 1488 - 1495 - How to handle brain tumors after esophagectomy with curative intent: A single center 20-year experience(2023)
Authors: Stijn Vanstraelen, Lieven Depypere, Johnny Moons, Hans Van Veer, Toni Lerut, Philippe Nafteux
- Primary Surgery Not Inferior to Neoadjuvant Chemoradiotherapy for Esophageal Adenocarcinoma(2023)
Authors: Johnny Moons, Toni Lerut, Lieven Depypere, Hans Van Veer, Philippe Nafteux
Pages: 571 - 578 - Lung Transplant Outcome From Selected Older Donors (≥70 Years) Equals Younger Donors (<70 Years) A Propensity-matched Analysis(2023)
Authors: Christelle Vandervelde, Robin Vos, Jan Van Slambrouck, Steffen Fieuws, Paul De Leyn, Philippe Nafteux, Hans Van Veer, Lieven Depypere, Arne Neyrinck, Catherine Ingels, et al.
Pages: E641 - E649